Everand Logo

Welcome to Everand!

  • STAT

    STAT+: Pharmalittle: We’re reading about a 486% drug price hike, AstraZeneca CEO pay, and more

    Is there any circumstance when a 486% increase for a medicine might be justified? A small company called Harrow argues the case for an injectable eye treatment.
    by Ed Silverman Apr 10, 2024 1 minute
    Source: Alex Hogan/STAT

    Hello, everyone, and how are you today? We are doing just fine, thank you, especially since the middle of the week is upon us. After all, we have made it this far, so we are determined

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT1 min read
    STAT+: Nuclear Regulatory Commission Advisers Beset By Conflicts Of Interest, Report Finds
    Advisers to the Nuclear Regulatory Commission, a U.S. government agency tasked with ensuring the safe use of radioactive materials, were beset by conflicts of interest, report finds
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About BIO’s China Challenge, Zepbound Shortages, And More
    BIO's about-face in its relationship with WuXi AppTec illustrates the difficulty the biotech industry faces in dealing with an issue that is moving fast and forcefully.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About An OptumRx Contract, 340B Dispute Resolution, And More
    Cardinal Health announced its pharmaceutical distribution contracts with UnitedHealth's OptumRx unit will not be renewed after they expire in June.

    Related Books & Audiobooks